Simeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial-Reference-Cited by-同舟云学术

Simeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial

Published:2014-08 Issue:2 Volume:61 Page:219-227
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Hayashi Norio,Izumi Namiki,Kumada Hiromitsu,Okanoue Takeshi,Tsubouchi Hirohito,Yatsuhashi Hiroshi,Kato Mai,Ki Rito,Komada Yuji,Seto Chiharu,Goto Shoichiro

Publisher

Elsevier BV

Subject

Hepatology

Reference26 articles.

1. Changing trends in hepatitis C infection over the past 50years in Japan;Chung;Intervirology,2010

2. Epidemiology of hepatocellular carcinoma in Japan;Umemura;J Gastroenterol,2009

3. EASL Clinical Practice Guidelines: management of hepatitis C virus infection;European Association for the Study of the Liver;J Hepatol,2011

4. Diagnostic and treatment algorithm of the Japanese society of hepatology: a consensus-based practice guideline;Izumi;Oncology,2010

5. Peginterferon alpha-2a (40KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients;Kuboki;J Gastroenterol Hepatol,2007

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Micro-PET imaging of hepatitis C virus NS3/4A protease activity using a protease-activatable retention probe;Frontiers in Microbiology;2022-11-04

2. Retrospective multicentre study on the effectiveness of first‐line direct‐acting antivirals against hepatitis C virus genotype‐1;Journal of Clinical Pharmacy and Therapeutics;2022-02-28

3. Treatment progress and expansion in Japan: From interferon to direct-acting antiviral;Global Health & Medicine;2021-10-31

4. Decreased expression of interferon‐stimulated genes in B cells of patients with chronic hepatitis C during interferon‐free therapy potentially suggests the eradication of hepatitis C virus in the B cells: A cohort study;Health Science Reports;2020-07-15

5. JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study;Journal of Gastroenterology;2020-02-17